These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26132180)

  • 21. Emerging facade of menopausal hormone therapy.
    Rees M
    Semin Reprod Med; 2010 Sep; 28(5):351-9. PubMed ID: 20845235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 24. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IMS updated recommendations on postmenopausal hormone therapy.
    ; Pines A; Sturdee DW; Birkhäuser MH; Schneider HP; Gambacciani M; Panay N
    Climacteric; 2007 Jun; 10(3):181-94. PubMed ID: 17487645
    [No Abstract]   [Full Text] [Related]  

  • 26. Postmenopausal health: a reassessment post WHI.
    Rees MC
    Int J Fertil Womens Med; 2003; 48(2):55-6. PubMed ID: 12779290
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 28. Press statement. Breast cancer and hormone therapy: a looking-glass mirror?
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2007 Oct; 10(5):356-7. PubMed ID: 17852137
    [No Abstract]   [Full Text] [Related]  

  • 29. New trends in hormone therapy.
    Fenton A; Panay N
    Climacteric; 2009 Aug; 12(4):277-8. PubMed ID: 19811226
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormone therapy update. How to make sense of the new recommendations on postmenopausal hormone therapy.
    Harv Womens Health Watch; 2013 Mar; 20(7):3. PubMed ID: 23862210
    [No Abstract]   [Full Text] [Related]  

  • 31. [What to think of postmenopausal hormone replacement therapy after 2002? ].
    Ringa V; Uzan S
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):86-9. PubMed ID: 12718317
    [No Abstract]   [Full Text] [Related]  

  • 32. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.
    Studd J
    Gynecol Endocrinol; 2007 Nov; 23(11):665-71. PubMed ID: 17943531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts.
    Fournier A; Kernaleguen C; Panjo H; Clavel-Chapelon F; Ringa V
    Menopause; 2011 Feb; 18(2):219-23. PubMed ID: 21052030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy. How things have changed.
    Katz A
    AWHONN Lifelines; 2006; 10(2):103-5. PubMed ID: 16712571
    [No Abstract]   [Full Text] [Related]  

  • 35. Menopause and the Heart.
    Nkonde-Price C; Bender JR
    Endocrinol Metab Clin North Am; 2015 Sep; 44(3):559-64. PubMed ID: 26316243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen deficiency: education for all!
    Morris E; Currie H
    Menopause Int; 2013 Jun; 19(2):55. PubMed ID: 23778559
    [No Abstract]   [Full Text] [Related]  

  • 37. Women, children, and adolescents: the post-2015 agenda.
    Lancet; 2014 Sep; 384(9949):1159. PubMed ID: 25263667
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks of hormone therapy in the 50-59 year age group.
    van de Weijer PH
    Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen therapies--where are we now?].
    Ylikorkala O
    Duodecim; 2003; 119(22):2175-7. PubMed ID: 14702805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.